相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study
Ahmet Gul et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
NLRP3 Inflammasome Is a Target for Development of Broad-Spectrum Anti-Infective Drugs
James D. Thacker et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Sphingosine regulates the NLRP3-inflammasome and IL-1ß release from macrophages
Nadia M. Luheshi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
Oxidized Mitochondrial DNA Activates the NLRP3 Inflammasome during Apoptosis
Kenichi Shimada et al.
IMMUNITY (2012)
Caspase-4 Is Required for Activation of Inflammasomes
Gabriel Sollberger et al.
JOURNAL OF IMMUNOLOGY (2012)
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Jorge Henao-Mejia et al.
NATURE (2012)
The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases
Beckley K. Davis et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
The Emerging Role of Interleukin-1β in Autoinflammatory Diseases
Helen J. Lachmann et al.
ARTHRITIS AND RHEUMATISM (2011)
Pathogenesis of Kawasaki disease
K. Takahashi et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Glyburide Is Anti-inflammatory and Associated with Reduced Mortality in Melioidosis
Gavin C. K. W. Koh et al.
CLINICAL INFECTIOUS DISEASES (2011)
The Challenges of Gout Management in the Elderly
Lisa K. Stamp et al.
DRUGS & AGING (2011)
A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases
Nishkantha Arulkumaran et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Atopic dermatitis: a disease of altered skin barrier and immune dysregulation
Mark Boguniewicz et al.
IMMUNOLOGICAL REVIEWS (2011)
P2X7 Receptor-Dependent Intestinal Afferent Hypersensitivity in a Mouse Model of Postinfectious Irritable Bowel Syndrome
Christopher Keating et al.
JOURNAL OF IMMUNOLOGY (2011)
Pannexin-1 Is Required for ATP Release during Apoptosis but Not for Inflammasome Activation
Yan Qu et al.
JOURNAL OF IMMUNOLOGY (2011)
Cutting Edge: Reactive Oxygen Species Inhibitors Block Priming, but Not Activation, of the NLRP3 Inflammasome
Franz Bauernfeind et al.
JOURNAL OF IMMUNOLOGY (2011)
Blocking interleukin-1 beta in acute and chronic autoinflammatory diseases
C. A. Dinarello
JOURNAL OF INTERNAL MEDICINE (2011)
XOMA 052, a potent, high-affinity monoclonal antibody for the treatment of IL-1 beta-mediated diseases
Alexander M. Owyang et al.
MABS (2011)
A role for mitochondria in NLRP3 inflammasome activation
Rongbin Zhou et al.
NATURE (2011)
The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes
Rebecca C. Coll et al.
PLOS ONE (2011)
Interplay between redox status and inflammasome activation
Anna Rubartelli et al.
TRENDS IN IMMUNOLOGY (2011)
Extracellular ATP Is a Danger Signal Activating P2X7 Receptor in Lung Inflammation and Fibrosis
Nicolas Riteau et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Why not treat human cancer with interleukin-1 blockade?
Charles A. Dinarello
CANCER AND METASTASIS REVIEWS (2010)
Listeria monocytogenes Triggers AIM2-Mediated Pyroptosis upon Infrequent Bacteriolysis in the Macrophage Cytosol
John-Demian Sauer et al.
CELL HOST & MICROBE (2010)
Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease
K. Ikeda et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
XOMA 052, an Anti-IL-1β Monoclonal Antibody, Improves Glucose Control and β-Cell Function in the Diet-Induced Obesity Mouse Model
Alexander M. Owyang et al.
ENDOCRINOLOGY (2010)
Canakinumab for treatment of cryopyrin-associated periodic syndrome
Eugen Feist et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Anti-IL-1 molecules: New comers and new indications
Anna Molto et al.
JOINT BONE SPINE (2010)
Innate Immune Detection of Bacterial Virulence Factors Via the NLRC4 Inflammasome
Edward A. Miao et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Lack of the purinergic receptor P2X7 results in resistance to contact hypersensitivity
Felix C. Weber et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Listeria monocytogenes-Infected Human Peripheral Blood Mononuclear Cells Produce IL-1β, Depending on Listeriolysin O and NLRP3
Karolin Meixenberger et al.
JOURNAL OF IMMUNOLOGY (2010)
Inflammation and Fibrosis during Chlamydia pneumoniae Infection Is Regulated by IL-1 and the NLRP3/ASC Inflammasome
Xianbao He et al.
JOURNAL OF IMMUNOLOGY (2010)
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Peter Duewell et al.
NATURE (2010)
Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production
Hendrik Poeck et al.
NATURE IMMUNOLOGY (2010)
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Rongbin Zhou et al.
NATURE IMMUNOLOGY (2010)
The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses
Vijay A. K. Rathinam et al.
NATURE IMMUNOLOGY (2010)
The AIM2 inflammasome is critical for innate immunity to Francisella tularensis
Teresa Fernandes-Alnemri et al.
NATURE IMMUNOLOGY (2010)
Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria
Edward A. Miao et al.
NATURE IMMUNOLOGY (2010)
Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1 beta in type 2 diabetes
Seth L. Masters et al.
NATURE IMMUNOLOGY (2010)
Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R
Konrad Wilhelm et al.
NATURE MEDICINE (2010)
Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4
Bo Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome
Edward A. Miao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Intracellular DNA recognition
Veit Hornung et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Immunological and Inflammatory Functions of the Interleukin-1 Family
Charles A. Dinarello
ANNUAL REVIEW OF IMMUNOLOGY (2009)
The antihyperalgesic activity of a selective P2X7 receptor antagonist, A-839977, is lost in IL-1αβ knockout mice
Prisca Honore et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Sustained Effects of Interleukin-1 Receptor Antagonist Treatment in Type 2 Diabetes
Claus M. Larsen et al.
DIABETES CARE (2009)
Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1β release through pyrophosphates
Pablo Pelegrin et al.
EMBO JOURNAL (2009)
Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
Mohamed Lamkanfi et al.
JOURNAL OF CELL BIOLOGY (2009)
Pharmacological Characterization of Pannexin-1 Currents Expressed in Mammalian Cells
Weihong Ma et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors
Francois Ghiringhelli et al.
NATURE MEDICINE (2009)
Pyroptosis: host cell death and inflammation
Tessa Bergsbaken et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Probenecid, a gout remedy, inhibits pannexin 1 channels
William Silverman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2008)
Stimulation of Toll-like receptor 3 and 4 induces interleukin-1β maturation by caspase-8
Jonathan Maelfait et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Hydrogen sulfide augments neutrophil migration through enhancement of adhesion molecule expression and prevention of CXCR2 internalization: Role of ATP-sensitive potassium channels
Daniela Dal-Secco et al.
JOURNAL OF IMMUNOLOGY (2008)
Multiple nod-like receptors activate caspase 1 during Listeria monocytogenes infection
Sarah E. Warren et al.
JOURNAL OF IMMUNOLOGY (2008)
Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
Veit Hornung et al.
NATURE IMMUNOLOGY (2008)
A NOD2-NALP1 complex mediates caspase-1-dependent IL-1β secretion in response to Bacillus anthracis infection and muramyl dipeptide
Li-Chung Hsu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica
Catherine Dostert et al.
SCIENCE (2008)
Stimulation of rat erythrocyte P2X7 receptor induces the release of epoxyeicosatrienoic acids
H. Jiang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome
Fayyaz S. Sutterwala et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
COPs and POPs: Modulators of inflammasome activity
Christian Stehlik et al.
JOURNAL OF IMMUNOLOGY (2007)
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration
V. Petrilli et al.
CELL DEATH AND DIFFERENTIATION (2007)
Polymorphisms in NACHT-LRR (NLR) genes in atopic dermatitis
Filippina Macaluso et al.
EXPERIMENTAL DERMATOLOGY (2007)
Pyrin levels in human monocytes and monocyte-derived macrophages regulate IL-1β processing and release
Sudarshan Seshadri et al.
JOURNAL OF IMMUNOLOGY (2007)
Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling
Joseph A. Duncan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Targeting caspase-1 by inhalation-therapy:: effects of Ac-YVAD-CHO on IL-1β, IL-18 and downstream proinflammatory parameters as detected in rat endotoxaemia
Kim A. Boost et al.
INTENSIVE CARE MEDICINE (2007)
(S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1β and IL-18
Woods Wannamaker et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
NALP1 in vitiligo-associated multiple autoimmune disease
Ying Jin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation
Benjamin Faustin et al.
MOLECULAR CELL (2007)
Pannexin-1 couples to maitotoxin- and nigericin-induced interleukin-1β release through a dye uptake-independent pathway
Pablo Pelegrin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Inflammatory caspases and inflammasomes: master switches of inflammation
F. Martinon et al.
CELL DEATH AND DIFFERENTIATION (2007)
Characterization of a selective and potent antagonist of human P2X7 receptors, AZ11645373
L. Stokes et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptor
Pablo Pelegrin et al.
EMBO JOURNAL (2006)
Cryopyrin activates the inflammasome in response to toxins and ATP
S Mariathasan et al.
NATURE (2006)
Gout-associated uric acid crystals activate the NALP3 inflammasome
F Martinon et al.
NATURE (2006)
Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin
ED Boyden et al.
NATURE GENETICS (2006)
Pannexin membrane channels are mechanosensitive conduits for ATP
L Bao et al.
FEBS LETTERS (2004)
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
S Mariathasan et al.
NATURE (2004)
Glutathione S-transferase omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1β posttranslational processing
RE Laliberte et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The effect of N-acetylcysteine on nuclear factor-KB activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis
RL Paterson et al.
CRITICAL CARE MEDICINE (2003)
The inflammasome:: A molecular platform triggering activation of inflammatory caspases and processing of proIL-β
F Martinon et al.
MOLECULAR CELL (2002)
Absence of the P2X7 receptor alters leukocyte function and attenuates an inflammatory response
JM Labasi et al.
JOURNAL OF IMMUNOLOGY (2002)
Therapeutic application of caspase 1/interleukin-1-beta-converting enzyme inhibitor decreases the death rate in severe acute experimental pancreatitis
AS Paszkowski et al.
ANNALS OF SURGERY (2002)
Toll-like receptors and innate immunity
R Medzhitov
NATURE REVIEWS IMMUNOLOGY (2001)
Altered cytokine production in mice lacking P2X7 receptors
M Solle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
